Literature DB >> 16055693

Myocardial infarct: depiction with contrast-enhanced MR imaging--comparison of gadopentetate and gadobenate.

Thomas Schlosser1, Peter Hunold, Christoph U Herborn, Heidrun Lehmkuhl, Alexander Lind, Sandra Massing, Jörg Barkhausen.   

Abstract

Institutional review board approval and patient written informed consent were obtained. On two separate occasions, 24 hours apart, contrast-enhanced cardiac magnetic resonance (MR) imaging was performed prospectively at 1, 3, 5, 10, and 20 minutes after injection of gadopentetate dimeglumine and gadobenate dimeglumine in 15 patients (11 men, four women) with history of myocardial infarction. Both agents allowed detection of infarcted myocardium. T1 values at all times were significantly (P < .05) lower for gadobenate, compared with values for gadopentetate, in both infarcted and noninfarcted myocardium. At 1 minute after administration of both agents, T1 values in left ventricular cavity (LVC) were not different; at 3-20 minutes after injection, values were significantly (P < .05) lower for gadobenate. Differences between contrast-to-noise ratio (CNR) values of infarcted and noninfarcted myocardium were significantly higher on gadobenate-enhanced images (P < .05). CNR values between infarcted myocardium and LVC were significantly higher on gadopentetate-enhanced images (P < .05). Gadopentetate might permit better delineation of infarcts, especially subendocardial infarcts.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16055693     DOI： 10.1148/radiol.2363040220

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  19 in total

1.  Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine.

Authors:  Moritz Wagner; Rene Schilling; Patrick Doeblin; Alexander Huppertz; Reny Luhur; Carsten Schwenke; Martin Maurer; Bernd Hamm; Matthias Taupitz; Tahir Durmus
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

2.  Magnetic resonance coronary angiography with Vasovist: in-vivo T1 estimation to improve image quality of navigator and breath-hold techniques.

Authors:  Kai Nassenstein; Kai-Uwe Waltering; Sebastian Kelle; Thomas Schlosser; Frank Breuckmann; Stefan Maderwald; Peter Hunold; Eike Nagel; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2007-08-14       Impact factor: 5.315

3.  Quantitative inversion time prescription for myocardial late gadolinium enhancement using T1-mapping-based synthetic inversion recovery imaging: reducing subjectivity in the estimation of inversion time.

Authors:  Sebastian Gassenmaier; Rob J van der Geest; U Joseph Schoepf; Pal Suranyi; Wolfgang G Rehwald; Carlo N De Cecco; Domenico Mastrodicasa; Moritz H Albrecht; Domenico De Santis; Virginia W Lesslie; Balazs Ruzsics; Akos Varga-Szemes
Journal:  Int J Cardiovasc Imaging       Date:  2018-01-05       Impact factor: 2.357

4.  [Late gadolinium enhancement in the diagnostics of ischemic heart disease: technical principles, contrast optimization and clinical application].

Authors:  K U Bauner; A Biffar; M Greif; A Becker; M Picciolo; D Theisen; T A Sandner; M Notohamiprodjo; M F Reiser; B J Wintersperger
Journal:  Radiologe       Date:  2010-06       Impact factor: 0.635

5.  CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis.

Authors:  James A White; Han W Kim; Dipan Shah; Nowell Fine; Ki-Young Kim; David C Wendell; Wael Al-Jaroudi; Michele Parker; Manesh Patel; Femida Gwadry-Sridhar; Robert M Judd; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

6.  Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.

Authors:  G D E Papini; S Tritella; F Secchi; A Aliprandi; G Di Leo; F Sardanelli
Journal:  Radiol Med       Date:  2010-03-09       Impact factor: 3.469

7.  Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine.

Authors:  Nadine Kawel; Marcelo Nacif; Francesco Santini; Songtao Liu; Jens Bremerich; Andrew E Arai; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2012-04-05       Impact factor: 4.813

8.  MR relaxometry and perfusion of the myocardium in spontaneously hypertensive rat: correlation with histopathology and effect of anti-hypertensive therapy.

Authors:  Jérôme Caudron; Paul Mulder; Lionel Nicol; Vincent Richard; Christian Thuillez; Jean-Nicolas Dacher
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

9.  Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement.

Authors:  Gabriele A Krombach; Christa Hahnen; Klaus-Peter Lodemann; Nils Krämer; Felix Schoth; Mirja Neizel; Jan Boeringer; Rolf W Günther; Malte Kelm; Harald Kühl
Journal:  Eur Radiol       Date:  2009-04-17       Impact factor: 5.315

10.  Left ventricular infarct size assessed with 0.1 mmol/kg of gadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine.

Authors:  Monravee Tumkosit; Chirapa Puntawangkoon; Tim M Morgan; Hollins P Clark; Craig A Hamilton; William O Ntim; Paige B Clark; W Gregory Hundley
Journal:  J Comput Assist Tomogr       Date:  2009 May-Jun       Impact factor: 1.826
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.